Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0014-2999(88)90677-2 | DOI Listing |
Eur J Pharmacol
July 1990
Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Harlow, Essex, U.K.
Clozapine, an atypical neuroleptic drug devoid of extrapyramidal side effects, was a moderately potent, competitive inhibitor of the binding of [3H]quaternised ICS 205-930 to 5-HT3 receptor sites in rat cortical membranes, possessing a pKi value of 7.0. In contrast, several other antipsychotic agents, including fluphenazine, alpha-flupenthixol, haloperidol, spiperone and (-)-sulpiride were essentially inactive.
View Article and Find Full Text PDFEur J Pharmacol
May 1988
Department of Biochemistry, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, U.K.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!